Rubix LS

About:

Rubix LS primary goal is to eradicate rare diseases through transformative research and development, breakthroughs in engineering.

Website: https://www.rubixls.com

Twitter/X: rubix_ls

Description:

Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes. At Rubix LS, we understand that practical therapeutic innovation doesn’t just happen within the lab; it occurs throughout the entire patient journey. Enabling better and diverse health outcomes starts by designing your early-stage development focus that encompasses various data sets.

Total Funding Amount:

$1.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lawrence, Massachusetts, United States

Founded Date:

2016-02-02

Contact Email:

info(AT)rubixls.com

Founders:

Reginald Swift

Number of Employees:

11-50

Last Funding Date:

2021-02-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai